Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells (Q39590723)

13 September 2017

Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells (English)

1 reference

13 September 2017

0 references

Yaohua Liu

1

1 reference

13 September 2017

Yuan Liang

2

1 reference

13 September 2017

Tianhu Zheng

3

1 reference

13 September 2017

Guang Yang

4

1 reference

13 September 2017

Xu Zhang

5

1 reference

13 September 2017

Zhe Sun

6

1 reference

13 September 2017

Changbin Shi

7

1 reference

13 September 2017

Shiguang Zhao

8

1 reference

13 September 2017

17 February 2011

1 reference

Journal of Neuro-Oncology

13 September 2017

1 reference

13 September 2017

104

1 reference

13 September 2017

2

1 reference

13 September 2017

449-458

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-010-0513-1

13 September 2017

0 references

cites work

Neuro-oncology: the growing role of chemotherapy in glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Down-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Intravenous administration of arsenic trioxide encapsulated in liposomes inhibits the growth of C6 gliomas in rat brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Arsenical-based cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Nrf2 controls constitutive and inducible expression of ARE-driven genes through a dynamic pathway involving nucleocytoplasmic shuttling by Keap1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Suppression of Nrf2-driven heme oxygenase-1 enhances the chemosensitivity of lung cancer A549 cells toward cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap n collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Gene expression profiling of NRF2-mediated protection against oxidative injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Targeting NRF2 signaling for cancer chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Nitric oxide activation of Keap1/Nrf2 signaling in human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Heme oxygenase-1 in tumors: is it a false friend?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Biliverdin reductase: a major physiologic cytoprotectant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-010-0513-1

Development of gliomas: potential role of asymmetrical cell division of neural stem cells

21 January 2018

1 reference

12 December 2020

Paradoxical effects of metalloporphyrins on doxorubicin-induced apoptosis: scavenging of reactive oxygen species versus induction of heme oxygenase-1

1 reference

12 December 2020

Effect of As2O3 on cell cycle progression and cyclins D1 and B1 expression in two glioblastoma cell lines differing in p53 status

1 reference

12 December 2020

Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.

1 reference

12 December 2020

Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients

1 reference

12 December 2020

Mechanisms of action of arsenic trioxide.

1 reference

12 December 2020

10.1007/S11060-010-0513-1

Identifiers

DOI

1 reference

13 September 2017

1 reference